Angiography is a procedure of diagnostic imaging to detect abnormalities of blood vessels. The X-ray image obtained by the angiography procedure is called as angiogram. In angiography, a special dye, also known as contrast medium, is injected in the body through a thin tube of plastic known as catheter. The dye makes the blood flowing through the blood vessels visible in the X-ray image. The procedure thus detects the abnormalities of blood vessels such as blockage, narrowing, inflammation, and bleeding inside the blood vessels. Angiography assists in angioplasty procedure, wherein a stent is inserted inside an artery when the narrowing of the artery is detected in the angiogram. Angiography is generally conducted by a radiologist or a trained medical professional who operates the X-ray machine. This procedure helps to diagnose disorders which are related to blood vessels and determine the treatment of these disorders.
Increasing prevalence of coronary heart diseases, and favorable reimbursement policies for the treatment of heart disorders are the major factors driving the growth of the angiography market during the forecast period. However, high cost of the procedure and fluctuating scenario regarding the upgradation of angiography devices are expected to restrict the growth of the market during the forecast period.
The global angiography market can be segmented on the basis of procedure type, application, product, end-user, and region. Based on the procedure type, the market is segmented into coronary angiography, cerebral angiography, renal angiography, pulmonary angiography, and others. The coronary angiography segment held a significant market share in 2016 owing to increasing awareness about congestive heart failure and rising demand for precise diagnostic imaging techniques for better diagnosis of the disease conditions. This segment is anticipated to continue to dominate the angiography market during the forecast period due to the introduction of advanced diagnostic techniques by key players operating in the global market. In terms of application, the market is segmented into congestive heart failure, coronary artery disorders, kidney disorders, and others. The coronary artery disorders segment accounted for a high market share in 2016 owing to favorable reimbursement policies by various private and public players and rising global geriatric population. Increase in public funding to improve the health care infrastructure in developing countries and rise in the prevalence of cardiovascular disorders worldwide are projected to drive the growth of coronary artery disorders and kidney disorders segments during the forecast period.
On the basis of product, the market is divided into angiography systems, catheters, incision closure devices, balloons, contrast media, and other accessories. The angiography systems segment captured a high market share in 2016 owing to its high cost. The segment is expected to continue to dominate the market during the forecast period due to increase in per capita expenditure of the population and launch of new products in the medical diagnostic field. Based on the end-user, the market is divided into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment held a significant market share in 2016 and is expected to continue to dominate the market during the forecast period owing to availability of trained and well-qualified health care professionals and technological advancements in diagnostic techniques.
Geographically, the market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 due to rising adoption rate of modern and novel medical imaging techniques. However, Asia Pacific is projected to expand at a high CAGR during the forecast period due to rising geriatric population and government participation for the improvement of the health care sector in India and Japan. Rising demand for efficient medical diagnostic techniques and increasing prevalence of coronary heart diseases are expected to propel the market growth in North America by 2025.
Prominent players operating in the global angiography market include GE Healthcare, St. Jude Medical, Inc., Abbott Laboratories, Shimadzu Corporation, Bayer Ag, Allengers, OSCOR Inc., Degania Silicone Ltd., and CathRx Ltd. among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.